Windlas Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million)
Windlas Biotech Ltd · Outcome · 05 Nov 2026, 9:48 pm
Windlas Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million) ■ Revenue: 2,639 (+18.7% YoY | +6.4% QoQ) ■ EBITDA: 294 (+2.8% YoY | +10.1% QoQ) ■ EBITDA Margin (%): 11.1 (-171 bps YoY | +37 bps QoQ) ■ PAT: 181 (+1.4% YoY | +2.3% QoQ) ■ EPS (INR): 8.56 (+1.9% YoY | +2.9% QoQ)
Original exchange filing (PDF)
More announcements from Windlas Biotech Ltd
- Q2 & H1 FY27 Earnings Conference Call Transcript · 13 Nov 2026
- Recording of Conference Call · 07 Nov 2026
- press release titled 'Windlas Biotech Limited Reports its H1 & Q2 FY27 Financial Results" · 05 Nov 2026
- Mr. Ashok Kumar Windlass, has been appointed, as Founder President (Senior Management Personnel) of the Company, effective from November 6, 2026. · 05 Nov 2026
- resignation of Mr. Ashok Kumar Windlass (DIN: 00011451) from the position of Whole-time Director and Director of the Company with effect from November 5, 2026 at 10.00 A.M. · 05 Nov 2026
- Investor Presentation - Q2 & H1FY27, · 05 Nov 2026
- Windlas Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 05 Nov 2026
- Approval inter alia unaudited financial results for the quarter and half year ended September 30, 2026 · 05 Nov 2026
